Queensland Bauxite Ltd

Queensland Bauxite Limited (ASX:QBL) is pleased to announce preliminary findings in relation to cannabinoid testing performed by its subsidiary Medical Cannabis Limited of some of MCL's low THC Cannabis cultivars. (THC is tetrahydrocannabinol Delta 9, a medical compound produced by Cannabis plants).

The Board of Queensland Bauxite (ASX:QBL) is pleased to announce that the Department of Natural Resources and Mines has now formally approved the work programme intended under the MDL.

The Board of Queensland Bauxite (ASX:QBL) is delighted to announce that Mineral Development License approval has been progressed for the South Johnstone Bauxite Project at Camp Creek in Queensland with the important decision received today from the DEHP to approve the amendment to our previous Environmental Authority, to allow for the work programme intended under the MDL.

Queensland Bauxite Ltd (ASX:QBL) is delighted to announce that its subsidiary company Medical Cannabis Limited has reported success with its previously announced winter trial crops.

During the June Quarter 2017, Queensland Bauxite Limited (ASX:QBL) continued to press to progress the development of its flagship South Johnstone DSO bauxite project in northern Queensland, with the Company aiming to generate positive net cash flows in the short term through the commencement of DSO bauxite production and shipping.

This is a reminder notice that your options to subscribe for ordinary fully paid shares in Queensland Bauxite Limited (ASX:QBL) will expire at 5:00pm Australian Western Standard Time on 31 July 2017.

Queensland Bauxite Ltd (ASX:QBL) is excited to announce that Medical Cannabis Limited has confirmed successful germination and growth rates of its pioneering winter Cannabis crop.

It has come the attention of Queensland Bauxite Ltd (ASX:QBL) that there has been some confusion between Andrew Kavasilas of Medical Cannabis Limited and Andrew Katelaris. Andrew Katelaris, Dr Pot, allegedly caught last week with cash and cannabis, and consequently arrested, is NOT the Andrew Kavasilas of Medical Cannabis Limited.

The directors of Queensland Bauxite Ltd (ASX:QBL) are excited to inform our shareholders that completion of the acquisition of 55% of MCL has occurred today with the issue of 49 million shares in QBL to the shareholders of MCL.

As the directors of Medical Cannabis Limited (MCL) are drafting a prospectus for an independent ASX listing of MCL, the Board of MCL in conjunction with the QBL (ASX:QBL) Board, have decided that the MCL Initial Public Offering (IPO) will be giving Queensland Bauxite shareholders preference to take up shares in the anticipated MCL Listing on ASX.